Latest Breaking News On - Practice guideline - Page 1 : comparemela.com

Only 28 33% of Spanish Physiotherapists Follow Fibromyalgia Guidelines

Only 28 33% of Spanish Physiotherapists Follow Fibromyalgia Guidelines
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

United statesItalian rheumatology societyUniversity of miguel hernAmerican pain societyEuropean alliance of associationsItalian society for rheumatologyClinical practice guidelinesMiguel hernSpain societyEuropean alliancePractice guidelineRheum disItalian society

Recommendations issued for palliative radiation therapy for symptomatic bone metastases

Recommendations issued for palliative radiation therapy for symptomatic bone metastases
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesSara alcornSarah alcornUniversity of minnesotaAmerican society for radiation oncologyAmerican societyRadiation oncologyPractical radiation oncologyExternal beam radiation therapySymptomatic bone metastasesPractice guidelinePractical radiation

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35 1% proteinuria reduction vs placebo

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label.

Czech republicUnited statesParag mahantiDavid soergelPrnewswire novartisMarianne silkjMarlena abdinoorJonathan grahamDavid kavanaghSloan simpsonFaculty of medical sciences at newcastle universityUniversity of washingtonG steering committee memberMetabolism development unitEuropean renal associationNovartis pharmaceuticals corporation

Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company s IgA nephropathy (IgAN) portfolio

In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1%.

United statesJonathan grahamMarlena abdinoorSloan simpsonLoreto mdaParag mahantiLambers heerspinkBartonm endothelinMichael meoNovartis fabhaltaPrnewswire novartisEuropean renal associationFibrotic transcriptional networksNovartis pharmaceuticals corporationExchange commissionEndpoint analysis

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35 1% proteinuria reduction vs placebo

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35 1% proteinuria reduction vs placebo
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

United statesCzech republicImke kappesJonathan grahamMarlena abdinoorDavid kavanaghNicole zinsli sommParag mahantiMarianne silkjSatoshi sugimotoDavid soergelIsabella zinckSloan simpsonMichael meoExchange commissionUniversity of washington